760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab
oleh: William Redmond, Brendan Curti, John Cha, Walter Urba, Yoshinobu Koguchi, Brian Piening, Noriko Iwamoto, Takashi Shimada, Shu-Ching Chang
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2020-11-01 |
Deskripsi
No description available for this item.